CD8A and infection: Overall, enhancing CD8+ T cells by α4-1BB may translate into better protection from symptomatic SARS-CoV-2 disease, considering their established role in reducing disease severity by eliminating infected cells and not necessarily by preventing initial infection, as that would be a function of antibodies (6, 42).